NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $29,000 | -19.4% | 70,000 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | -10.0% | 70,000 | 0.0% | 0.00% | – |
| Q1 2017 | $40,000 | -9.1% | 70,000 | 0.0% | 0.00% | – |
| Q4 2016 | $44,000 | -31.2% | 70,000 | 0.0% | 0.00% | – |
| Q3 2016 | $64,000 | +73.0% | 70,000 | 0.0% | 0.00% | – |
| Q2 2016 | $37,000 | -43.9% | 70,000 | -0.6% | 0.00% | – |
| Q1 2016 | $66,000 | -29.8% | 70,400 | 0.0% | 0.00% | – |
| Q4 2015 | $94,000 | -41.2% | 70,400 | +0.6% | 0.00% | – |
| Q3 2015 | $160,000 | +41.6% | 70,000 | 0.0% | 0.00% | – |
| Q2 2015 | $113,000 | +1.8% | 70,000 | 0.0% | 0.00% | – |
| Q1 2015 | $111,000 | +46.1% | 70,000 | +75.0% | 0.00% | – |
| Q4 2014 | $76,000 | +43.4% | 40,000 | 0.0% | 0.00% | – |
| Q3 2014 | $53,000 | -10.2% | 40,000 | 0.0% | 0.00% | – |
| Q2 2014 | $59,000 | -20.3% | 40,000 | 0.0% | 0.00% | – |
| Q1 2014 | $74,000 | -28.8% | 40,000 | -20.0% | 0.00% | – |
| Q4 2013 | $104,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |